These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25635808)

  • 1. Sensitivity analysis for missing outcomes in time-to-event data with covariate adjustment.
    Zhao Y; Saville BR; Zhou H; Koch GG
    J Biopharm Stat; 2016; 26(2):269-79. PubMed ID: 25635808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dealing with missing outcome data in randomized trials and observational studies.
    Groenwold RH; Donders AR; Roes KC; Harrell FE; Moons KG
    Am J Epidemiol; 2012 Feb; 175(3):210-7. PubMed ID: 22262640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonparametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 May; 9(2):307-38. PubMed ID: 10379696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imputation of missing covariate in randomized controlled trials with a continuous outcome: Scoping review and new results.
    Kayembe MT; Jolani S; Tan FES; van Breukelen GJP
    Pharm Stat; 2020 Nov; 19(6):840-860. PubMed ID: 32510791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?
    Hernández AV; Eijkemans MJ; Steyerberg EW
    Ann Epidemiol; 2006 Jan; 16(1):41-8. PubMed ID: 16275011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonparametric covariate adjustment in estimating hazard ratios.
    Jiang H; Kulkarni PM; Wang Y; Mallinckrodt CH
    Pharm Stat; 2016; 15(1):46-53. PubMed ID: 26610282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomization-based adjustment of multiple treatment hazard ratios for covariates with missing data.
    Lam D; Koch GG; Preisser JS; Saville BR; Hussey MA
    J Biopharm Stat; 2017; 27(3):373-386. PubMed ID: 28281895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level.
    Rombach I; Gray AM; Jenkinson C; Murray DW; Rivero-Arias O
    BMC Med Res Methodol; 2018 Aug; 18(1):87. PubMed ID: 30153796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonparametric randomization-based covariate adjustment for stratified analysis of time-to-event or dichotomous outcomes.
    Hussey MA; Koch GG; Preisser JS; Saville BR
    J Biopharm Stat; 2016; 26(3):579-89. PubMed ID: 26101805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covariate-adjusted non-parametric survival curve estimation.
    Jiang H; Symanowski J; Qu Y; Ni X; Wang Y
    Stat Med; 2011 May; 30(11):1243-53. PubMed ID: 21344475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonlinear multiple imputation for continuous covariate within semiparametric Cox model: application to HIV data in Senegal.
    Mbougua JB; Laurent C; Ndoye I; Delaporte E; Gwet H; Molinari N
    Stat Med; 2013 Nov; 32(26):4651-65. PubMed ID: 23712767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bias and Precision of the "Multiple Imputation, Then Deletion" Method for Dealing With Missing Outcome Data.
    Sullivan TR; Salter AB; Ryan P; Lee KJ
    Am J Epidemiol; 2015 Sep; 182(6):528-34. PubMed ID: 26337075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating covariate-adjusted log hazard ratios in randomized clinical trials using cox proportional hazards models and nonparametric randomization based analysis of covariance.
    Saville BR; Koch GG
    J Biopharm Stat; 2013 Mar; 23(2):477-90. PubMed ID: 23437952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missing data sensitivity analysis for recurrent event data using controlled imputation.
    Keene ON; Roger JH; Hartley BF; Kenward MG
    Pharm Stat; 2014; 13(4):258-64. PubMed ID: 24931317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A note on dealing with missing standard errors in meta-analyses of continuous outcome measures in WinBUGS.
    Stevens JW
    Pharm Stat; 2011; 10(4):374-8. PubMed ID: 21394888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing survival functions with interval-censored data in the presence of an intermediate clinical event.
    Kim S; Kim J; Nam CM
    BMC Med Res Methodol; 2018 Oct; 18(1):98. PubMed ID: 30285636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covariate adjustment in randomized clinical trials with missing covariate and outcome data.
    Chang CR; Song Y; Li F; Wang R
    Stat Med; 2023 Sep; 42(22):3919-3935. PubMed ID: 37394874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of linear transformation models with covariate measurement error and interval censoring.
    Mandal S; Wang S; Sinha S
    Stat Med; 2019 Oct; 38(23):4642-4655. PubMed ID: 31347177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.